57894-514-01 : NDC 2026 Code

57894-514-01 : Amivantamab And Hyaluronidase-lpuj (human Recombinant) ( Rybrevant Faspro )

Additionally :

You can get information about “57894-514-01” NDC code in 57894-514-01 in HTML format

HTML | 57894-514-01 in TXT (Plain Text) format

TXT | 57894-514-01 in PDF (Portable Document Format)

PDF | 57894-514-01 in XML format

XML formats.

NDC Code : 57894-514-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "57894-514-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01)  / 14 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "57894-0514-01",
    "ProductNDC": "57894-514",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Rybrevant Faspro",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Amivantamab And Hyaluronidase-lpuj (human Recombinant)",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20251217",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761433",
    "LabelerName": "Janssen Biotech, Inc.",
    "SubstanceName": "AMIVANTAMAB; HYALURONIDASE (HUMAN RECOMBINANT)",
    "StrengthNumber": "2240; 28000",
    "StrengthUnit": "mg/14mL; mg/14mL",
    "Pharm_Classes": "Endoglycosidase [EPC], Glycoside Hydrolases [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251217",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}